skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: NS5A inhibitors unmask differences in functional replicase complex half-life between different hepatitis C virus strains

Abstract

We synthesized the Hepatitis C virus (HCV) RNA by the replicase complex (RC), a macromolecular assembly composed of viral non-structural proteins and cellular co-factors. Inhibitors of the HCV NS5A protein block formation of new RCs but do not affect RNA synthesis by preformed RCs. Without new RC formation, existing RCs turn over and are eventually lost from the cell. We aimed to use NS5A inhibitors to estimate the half-life of the functional RC of HCV. We compared different cell culture-infectious strains of HCV that may be grouped based on their sensitivity to lipid peroxidation: robustly replicating, lipid peroxidation resistant (LPO R) viruses (e.g. JFH-1 or H77D) and more slowly replicating, lipid peroxidation sensitive (LPO S) viruses (e.g. H77S.3 and N.2). Furthermore, in luciferase assays, LPO S HCV strains declined under NS5A inhibitor therapy with much slower kinetics compared to LPO R HCV strains. This difference in rate of decline was not observed for inhibitors of the NS5B RNAdependent RNA polymerase suggesting that the difference was not simply a consequence of differences in RNA stability. In further analyses, we compared two isoclonal HCV variants: the LPO S H77S.3 and the LPO R H77D that differ only by 12 amino acids. Differencesmore » in rate of decline between H77S.3 and H77D following NS5A inhibitor addition were not due to amino acid sequences in NS5A but rather due to a combination of amino acid differences in the non-structural proteins that make up the HCV RC. The mathematical modeling of intracellular HCV RNA dynamics suggested that differences in RC stability (half-lives of 3.5 and 9.9 hours, for H77D and H77S.3, respectively) are responsible for the different kinetics of antiviral suppression between LPO S and LPO R viruses. In nascent RNA capture assays, the rate of RNA synthesis decline following NS5A inhibitor addition was significantly faster for H77D compared to H77S.3 indicating different half-lives of functional RCs.« less

Authors:
 [1];  [2]; ORCiD logo [3];  [3]; ORCiD logo [4];  [4];  [1]; ORCiD logo [5];  [2]; ORCiD logo [1];  [6]
  1. Univ. of North Carolina, Chapel Hill, NC (United States). Lineberger Comprehensive Cancer Center and Dept. of Medicine
  2. North Carolina State Univ., Raleigh, NC (United States). Dept. of Mathematics
  3. Univ. of North Carolina, Chapel Hill, NC (United States). Lineberger Comprehensive Cancer Center
  4. National Inst. of Molecular Genetics (INGM), Milan (Italy)
  5. Los Alamos National Lab. (LANL), Los Alamos, NM (United States). Theoretical Biology and Biophysics
  6. Univ. of Chicago, IL (United States)
Publication Date:
Research Org.:
Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE; National Institutes of Health (NIH)
OSTI Identifier:
1375872
Report Number(s):
LA-UR-17-20265
Journal ID: ISSN 1553-7374
Grant/Contract Number:  
AC52-06NA25396; R21-AI115207 (DRM); R01-AI095690 (SML); R01-AI078881 (ASP); R01- AI028433 (ASP); OD-011095 (ASP)
Resource Type:
Accepted Manuscript
Journal Name:
PLoS Pathogens
Additional Journal Information:
Journal Volume: 13; Journal Issue: 6; Journal ID: ISSN 1553-7374
Publisher:
Public Library of Science
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES; Biological Science

Citation Formats

Benzine, Tiffany, Brandt, Ryan, Lovell, William C., Yamane, Daisuke, Neddermann, Petra, De Francesco, Raffaele, Lemon, Stanley M., Perelson, Alan S., Ke, Ruian, McGivern, David R., and Randall, Glenn. NS5A inhibitors unmask differences in functional replicase complex half-life between different hepatitis C virus strains. United States: N. p., 2017. Web. doi:10.1371/journal.ppat.1006343.
Benzine, Tiffany, Brandt, Ryan, Lovell, William C., Yamane, Daisuke, Neddermann, Petra, De Francesco, Raffaele, Lemon, Stanley M., Perelson, Alan S., Ke, Ruian, McGivern, David R., & Randall, Glenn. NS5A inhibitors unmask differences in functional replicase complex half-life between different hepatitis C virus strains. United States. doi:10.1371/journal.ppat.1006343.
Benzine, Tiffany, Brandt, Ryan, Lovell, William C., Yamane, Daisuke, Neddermann, Petra, De Francesco, Raffaele, Lemon, Stanley M., Perelson, Alan S., Ke, Ruian, McGivern, David R., and Randall, Glenn. Thu . "NS5A inhibitors unmask differences in functional replicase complex half-life between different hepatitis C virus strains". United States. doi:10.1371/journal.ppat.1006343. https://www.osti.gov/servlets/purl/1375872.
@article{osti_1375872,
title = {NS5A inhibitors unmask differences in functional replicase complex half-life between different hepatitis C virus strains},
author = {Benzine, Tiffany and Brandt, Ryan and Lovell, William C. and Yamane, Daisuke and Neddermann, Petra and De Francesco, Raffaele and Lemon, Stanley M. and Perelson, Alan S. and Ke, Ruian and McGivern, David R. and Randall, Glenn},
abstractNote = {We synthesized the Hepatitis C virus (HCV) RNA by the replicase complex (RC), a macromolecular assembly composed of viral non-structural proteins and cellular co-factors. Inhibitors of the HCV NS5A protein block formation of new RCs but do not affect RNA synthesis by preformed RCs. Without new RC formation, existing RCs turn over and are eventually lost from the cell. We aimed to use NS5A inhibitors to estimate the half-life of the functional RC of HCV. We compared different cell culture-infectious strains of HCV that may be grouped based on their sensitivity to lipid peroxidation: robustly replicating, lipid peroxidation resistant (LPOR) viruses (e.g. JFH-1 or H77D) and more slowly replicating, lipid peroxidation sensitive (LPOS) viruses (e.g. H77S.3 and N.2). Furthermore, in luciferase assays, LPOS HCV strains declined under NS5A inhibitor therapy with much slower kinetics compared to LPOR HCV strains. This difference in rate of decline was not observed for inhibitors of the NS5B RNAdependent RNA polymerase suggesting that the difference was not simply a consequence of differences in RNA stability. In further analyses, we compared two isoclonal HCV variants: the LPOS H77S.3 and the LPOR H77D that differ only by 12 amino acids. Differences in rate of decline between H77S.3 and H77D following NS5A inhibitor addition were not due to amino acid sequences in NS5A but rather due to a combination of amino acid differences in the non-structural proteins that make up the HCV RC. The mathematical modeling of intracellular HCV RNA dynamics suggested that differences in RC stability (half-lives of 3.5 and 9.9 hours, for H77D and H77S.3, respectively) are responsible for the different kinetics of antiviral suppression between LPOS and LPOR viruses. In nascent RNA capture assays, the rate of RNA synthesis decline following NS5A inhibitor addition was significantly faster for H77D compared to H77S.3 indicating different half-lives of functional RCs.},
doi = {10.1371/journal.ppat.1006343},
journal = {PLoS Pathogens},
number = 6,
volume = 13,
place = {United States},
year = {2017},
month = {6}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 3 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Molecular wear of microtubules propelled by surface-adhered kinesins
journal, January 2015

  • Dumont, Emmanuel L. P.; Do, Catherine; Hess, Henry
  • Nature Nanotechnology, Vol. 10, Issue 2
  • DOI: 10.1038/nnano.2014.334

Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle
journal, March 2015

  • McGivern, David R.; Masaki, Takahiro; Lovell, William
  • Journal of Virology, Vol. 89, Issue 10
  • DOI: 10.1128/JVI.03188-14

Replication Vesicles are Load- and Choke-Points in the Hepatitis C Virus Lifecycle
journal, August 2013


Protease Inhibitor–Resistant Hepatitis C Virus Mutants With Reduced Fitness From Impaired Production of Infectious Virus
journal, February 2011


Quantitative Analysis of the Hepatitis C Virus Replication Complex
journal, October 2005


Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
journal, April 2010

  • Gao, Min; Nettles, Richard E.; Belema, Makonen
  • Nature, Vol. 465, Issue 7294
  • DOI: 10.1038/nature08960

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
journal, February 2013

  • Guedj, J.; Dahari, H.; Rong, L.
  • Proceedings of the National Academy of Sciences, Vol. 110, Issue 10
  • DOI: 10.1073/pnas.1203110110

Analysis of the hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS-7977) and GS-0938
journal, January 2014

  • Guedj, Jeremie; Pang, Phillip S.; Denning, Jill
  • Antiviral Therapy, Vol. 19, Issue 2
  • DOI: 10.3851/IMP2733

Complete Replication of Hepatitis C Virus in Cell Culture
journal, July 2005


Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors
journal, August 2014


Protein Friction Limits Diffusive and Directed Movements of Kinesin Motors on Microtubules
journal, August 2009


Recruitment and Activation of a Lipid Kinase by Hepatitis C Virus NS5A Is Essential for Integrity of the Membranous Replication Compartment
journal, January 2011


Regulation of Hepatitis C Virus Translation and Infectious Virus Production by the MicroRNA miR-122
journal, April 2010

  • Jangra, R. K.; Yi, M.; Lemon, S. M.
  • Journal of Virology, Vol. 84, Issue 13
  • DOI: 10.1128/JVI.00417-10